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Smoking is associated with shorter leucocyte telomere length (LTL), a biomarker of increased
morbidity and reduced longevity. This association is widely interpreted as evidence that smoking
causes accelerated LTL attrition in adulthood, but the evidence for this is inconsistent. We analysed
the association between smoking and LTL dynamics in 18 longitudinal cohorts. The dataset
included data from 12 579 adults (4678 current smokers and 7901 non-smokers) over a mean
follow-up interval of 8.6 years. Meta-analysis confirmed a cross-sectional difference in LTL between
smokers and non-smokers, with mean LTL 84.61 bp shorter in smokers (95% CI: 22.62 to 146.61).
However, LTL attrition was only 0.51 bp yr21 faster in smokers than in non-smokers (95% CI:
22.09 to 1.08), a difference that equates to only 1.32% of the estimated age-related loss of
38.33 bp yr21. Assuming a linear effect of smoking, 167 years of smoking would be required to
generate the observed cross-sectional difference in LTL. Therefore, the difference in LTL between
smokers and non-smokers is extremely unlikely to be explained by a linear, causal effect of
smoking. Selective adoption, whereby individuals with short telomeres are more likely to start
smoking, needs to be considered as a more plausible explanation for the observed pattern of
telomere dynamics.1. Introduction
Leucocyte telomere length (LTL)—the length of the repeated TTAGGG sequence at the end of leucocyte
chromosomes—is an extensively studied biomarker of human health and well-being. In support of a link
between poorer health and shorter average LTL, many cross-sectional studies have found an association
between tobacco smoking and shorter LTL [1,2]. Since human telomeres shorten with age, these data are
widely interpreted as demonstrating that smoking accelerates the rate of biological ageing [1,3,4]. For
example, Valdes et al. [3] concluded, ‘Our findings suggest that obesity and cigarette smoking
accelerate human ageing . . . smoking a pack a day for 40 years corresponds to 7.4 years of ageing’.
Thus, the telomere data are invoked to support a more general claim that smoking is a potent
gerontogen, or ageing accelerator [5,6].
Smoking undoubtedly has a myriad of negative effects on human health and longevity. Moreover,
the hypothesis that smoking causes telomere attrition is mechanistically plausible. Smoking causes
increased levels of oxidative stress and inflammation [7–9], both of which are implicated in telomere
attrition [10]. In vitro studies show that oxidative stress increases telomere attrition by increasing
telomere loss per cell replication in a dose-dependent manner [11,12]. Smoking is therefore assumed
to accelerate the rate of telomere attrition. Thus, although correlation does not provide evidence for
causation, the hypothesis that smoking causes accelerated telomere attrition in vivo has been
uncritically accepted based on cross-sectional data, and alternative explanations for the observed
association between smoking and LTL have not been considered. However, evidence has started to
accumulate that challenges this view. First, predicted links between oxidative stress and telomere
attrition in vivo are proving elusive [13]. Second, a Mendelian randomization study that used a genetic
polymorphism (CHRNA3 genotype) established to be strongly associated with tobacco consumption
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Figure 1. Three alternative models to explain the observed association between smoking and LTL: (a) causation, (b) selective
adoption, and (c) mixed (¼causation þ selective adoption). We assume that smoking starts at t0 for smokers and continues
thereafter, whereas non-smokers never smoke. The magenta line represents the telomere dynamics for smokers and the green
line for age-matched non-smokers. The dotted lines represent the position of two measurements of adult LTL (baseline and
follow-up) made after the start of smoking.
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3found no evidence to support a causal association between smoking and short telomeres [14]. Finally,
most of the variation in adult LTL is already present in early life, prior to the age at which most
children start smoking, and adult LTL rank is largely stable [15,16]. Thus, there appears to be little
scope for smoking to influence variation in adult LTL. Our aim in the current paper is therefore to use
a meta-analysis of longitudinal LTL attrition data to directly test the hypothesis that smoking causes a
sustained increase in the rate of LTL attrition in adults (henceforth the causation hypothesis). We
additionally propose an alternative hypothesis of selective adoption, whereby individuals with shorter
LTL are more likely to start smoking.
To generate testable predictions from the causation and selective adoption hypotheses we start by
stating their assumptions (figure 1). For smokers, we assume that from the point at which an
individual starts smoking, their LTL in subsequent years can be modelled as a straight line with a
positive intercept (cs) corresponding to their LTL at the start of smoking, and a negative slope (ms)
corresponding to their LTL attrition per year of smoking. For age-matched non-smokers, we also
assume that LTL can be modelled as a straight line with a positive intercept and negative slope with
values cn and mn respectively. The causation hypothesis assumes that prior to starting smoking there
is no difference in the LTL of future smokers and non-smokers (i.e. cs ¼ cn), but that after starting
smoking the rate of telomere attrition is higher for smokers than for non-smokers (ms. mn). By
contrast, selective adoption assumes that prior to starting smoking future smokers have shorter LTL
than future non-smokers (cs , cn), but after starting smoking the rate of LTL attrition is equal in
smokers and non-smokers (ms ¼ mn). Since causation and selective adoption are not mutually
exclusive, we also consider a mixed hypothesis that assumes that future smokers have shorter LTL
than future non-smokers (cs, cn) and after starting smoking the rate of LTL attrition is faster in
smokers than in non-smokers (ms . mn).
Two major predictions emerge from figure 1 that are tested here. First, all three hypotheses predict
that LTL for smokers should be shorter than LTL for non-smokers at any time-point following the
adoption of smoking. Thus, the observation of shorter LTL in adult smokers cannot be used to
distinguish between the hypotheses. Second, the selective adoption hypothesis is unique in
predicting that adult LTL attrition rate should be equal in current smokers and non-smokers,
whereas the causation and mixed hypotheses both predict faster attrition in smokers. There have
been a number of attempts to test this latter prediction using longitudinal LTL attrition data, but
they have produced inconsistent findings [17]. Whereas some studies report faster LTL attrition in
smokers [18,19], others report no difference [20–25] and one study reports faster LTL attrition in
non-smokers [26]. To discriminate selective adoption from the other hypotheses it is critical to
establish whether LTL attrition rates differ between smokers and non-smokers, and whether the
observed difference in attrition is sufficient to explain the observed cross-sectional difference in
LTL. Here we present the first quantitative meta-analysis aimed at estimating the effect of smoking
on the rate of LTL attrition. This analysis was based on all published datasets that we were able to
identify that contained relevant longitudinal measurements of LTL and information on smoking
status, regardless of whether the association between smoking and LTL dynamics had been
previously described.
royalsocietypublishing.org/journal/rsos
R.Soc.open
sci.6:190420
42. Methods
2.1. Search strategy and data eligibility requirements
We sought longitudinal cohort studies in which baseline and follow-up measurements of LTL were
obtained from each participant and in which data on smoking behaviour were also available. To
allow sufficient time for biologically meaningful changes in LTL to be observed, we required a follow-
up interval of at least 4 years [27].
Electronic supplementary material, figure S1 provides a PRISMA diagram summarizing how the data
were obtained. We performed a systematic literature search using ISI Web of Knowledge (Thomson
Scientific Technical Support, New York) for articles published prior to 2017 using the search terms:
‘telomere*’ and ‘longitudinal’ and ‘smoking’. Additional relevant articles were identified by
snowballing [28]. Articles were screened to identify potentially eligible cohorts. In many cases,
determining the effect of smoking on LTL attrition was not the primary aim of an article, but smoking
status was mentioned among the list of control variables.
In articles that reported estimates of the association between smoking and LTL attrition, the latter
estimates usually came from multiple regression models that had been adjusted for baseline LTL. This
practice is nearly universal due to the strong association present in most datasets between baseline
LTL and rate of LTL attrition arising largely as a consequence of regression to the mean [29]. We have
demonstrated that such adjusted estimates are likely to be biased in a direction that exaggerates the
true effect of smoking on LTL attrition [30]. Therefore, we sought unadjusted estimates of the
difference in LTL dynamics between smokers and non-smokers.
In two cases we were able to extract the required summary statistics from published articles, but for
the majority of eligible cohorts, summary statistics on raw LTL and LTL attrition for smokers and non-
smokers were not reported. Therefore, we contacted the authors and/or cohort managers to request
either the required summary statistics, or the full individual participant-level data. In order to ensure
consistency across cohorts in how the data were analysed, in the cases where we requested summary
statistics, we provided detailed instructions on how these were to be calculated (including any
exclusions—see below). In nine cases authors or cohort managers calculated and supplied the
required summary statistics, and in the remaining seven cases the first author (M.B.) obtained raw
data and calculated the summary statistics herself. For nine cohorts there were some published
findings available relating to the effect of smoking on LTL attrition rate (for a narrative review see
[17]), but for the other nine cohorts the first author was blind to the effect of smoking at the time of
requesting the data (see table 1 for details).
The following data were obtained for each cohort included in the meta-analysis: the number of
participants (smokers and non-smokers), mean age at baseline measurement (in years), mean follow-
up interval (in years), LTL measurement method (TRF or qPCR), LTL measurement units (base pairs
or T/S ratios), mean LTL at baseline and follow-up for smokers and non-smokers, standard deviation
of LTL length at baseline and follow-up for smokers and non-smokers, annual rate of LTL attrition for
smokers and non-smokers, standard deviation of LTL attrition per year for smokers and non-smokers,
and the Pearson correlation between LTL at baseline and follow-up measurements.
Participants were only included if they had LTL data at both baseline and follow-up; participants lost
to follow-up were excluded. In cohorts in which LTL was measured at more than two time-points
(LBC1921 and LBC1936) we only used the two LTL measurements that gave the longest follow-up
interval for each participant, designating the first as baseline and the second as follow-up. LTL
attrition rate for a participant was calculated via the following formula: LTL attrition rate (bp yr21) ¼
(LTLbaseline2 LTLfollow-up)/follow-up years.
We sought to only include data from participants who were either consistent never smokers or
consistent current smokers at baseline and follow-up; where possible, we excluded participants
who had quit smoking prior to baseline or between baseline and follow-up. We did not attempt to
explore the effects of amount smoked, since consistent data were not available for all cohorts. For
the majority of cohorts (15/18), smokers were defined as consistent current smokers at both
baseline and follow-up and non-smokers were defined as consistent never-smokers at baseline and
follow-up; individuals who changed smoking status between baseline and follow-up were
excluded. However, for one cohort (BRUNECK), smokers and non-smokers were defined based on
baseline status only, and for the two cohorts, for which data were extracted from published papers
(BHS and ESTHER), it was not clear whether the smoker/non-smoker classification was based on
status at baseline, follow-up or both.
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72.2. Statistical analysis
We analysed the data in the statistical programming language R, v. 3.3.3 [37], using the meta-analysis
package ‘metafor’ [38].
Since some cohorts reported LTL measurements in T/S ratios and others in base pairs, we computed
standardized mean differences (SMDs) between smokers and non-smokers for LTL and LTL attrition. We
used random-effects meta-analysis models throughout, because we deemed the cohorts too different to
justify assuming that there are common true effect sizes to estimate [39]. Unless otherwise stated, we
estimated parameters using inverse-variance weighting of cohorts (the default) and REML. In one of
our sensitivity analyses we instead weighted cohorts by the correlation between baseline and follow-
up LTL measurements (r). The rationale for this decision is that r has been argued to be a good proxy
for LTL measurement error [27,40], an assumption supported by the observation that datasets
measured with more precise TRF always have higher correlations than those measured with less
precise qPCR (as shown by the values in electronic supplementary material, table S1). To address the
fact that we had two LTL measurements from each cohort, and in some analyses we needed to either
compare the difference in SMDs between time-points (table 2, model 4), or combine SMDs across
time-points (table 2, model 5), we used the methods outlined in Borenstein et al. [39, chapter 24] for
computing effect sizes from complex data structures involving multiple time-points.
To facilitate interpretation of the summary SMDs derived from the meta-analyses we transformed
these effects into base pairs. To make these calculations, estimates of the standard deviations of either
LTL or LTL attrition rate were required, as appropriate. We estimated these standard deviations from
the four cohorts measured with TRF (ADE, BHS, ERA and JLRCS), because these cohorts were the
only ones for which LTL was originally measured in base pairs. We used weighted means of the four
estimates of s.d. obtained from each cohort to account for the fact that the precision of an estimate of
s.d. will increase with the square root of the sample size. The resulting estimates for the standard
deviation of LTL and LTL attrition rate were 675.88 bp and 24.82 bp yr21 respectively.3. Results
3.1. Characteristics of the dataset
We obtained data from 18 longitudinal cohorts spanning 10 countries and four continents (table 1 and
electronic supplementary material, table S1). The combined dataset included data from 12 579 adults
comprising 4678 current smokers and 7901 non-smokers. The mean age at baseline of the cohorts was
54.8+ 15.4 years (mean+ s.d.; range: 26.0–80.2). Given that tobacco use typically begins by age 16
[41], smokers in the dataset are likely to have already been smoking for at least a decade at the time
of the baseline telomere measurement. The mean follow-up interval was 8.6+ 2.2 years (mean+ s.d.;
range: 5.9–13.1).
Fourteen cohorts measured LTL using the quantitative polymerase chain reaction (qPCR) method and
four used the terminal restriction fragment method (TRF; ADE, BHS, ERA and JLRCS; electronic
supplementary material, table S1). The correlation between LTL at baseline and follow-up varied
considerably among cohorts: Pearson correlation coefficients (r) ranged from 0 to 0.66 for qPCR
measurements and from 0.92 to 0.97 for TRF measurements. These data suggest substantial variation
in LTL measurement error among cohorts and greater measurement error in the subset of cohorts
measured with qPCR.
3.2. Does leukocyte telomere length decrease with age?
To ascertain whether the telomere data were likely to be of sufficient quality to reveal effects of smoking
on LTL dynamics, we first asked whether average LTL was shorter at follow-up than at baseline (when
cohorts were a mean of 8.6 years younger). As expected, mean LTL was significantly shorter at follow-up,
both in the meta-analysis and in all but one of the individual cohorts (table 2, model 1; electronic
supplementary material, figure S2a). When we added the mean length of the follow-up interval to
model 1 as a moderator, the slope of the meta-regression was in the expected direction, with longer
follow-up intervals associated with larger declines in mean LTL between baseline and follow-up
(electronic supplementary material, figure S2b). Although the meta-regression was not significant
overall (parameter estimate and 95% CI: 20.02, [20.09, 0.04], p ¼ 0.4218), it was significant for
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(a) (b)
Figure 2. Smokers have shorter LTL than non-smokers at both baseline and follow-up. Forest plots showing the significant
associations between smoking and LTL at (a) baseline (model 2), and (b) follow-up (model 3). The squares show the observed
standardized mean difference (SMD) and the whiskers the 95% CI for each cohort; the area of each square is proportional to
the weight given to that cohort in the meta-analysis. Cohorts measured with qPCR are shown in red and cohorts measured
with TRF in blue. Significant differences are shown in bold. The black diamond shows the meta-analytic summary: the centre
depicts the mean effect and the width the 95% CI.
royalsocietypublishing.org/journal/rsos
R.Soc.open
sci.6:190420
9the subset of cohorts measured with TRF (parameter estimate and 95% CI: 20.03, [20.05, ,0.00], p ¼
0.0186). The estimated slope of the meta-regression was similar for both the whole dataset and the
TRF subset, suggesting that although qPCR measurements are less precise, there is little evidence
for bias.
Using the parameter estimate for the effect of age on LTL obtained from model 1 we calculated the
estimated decrease in LTL between baseline and follow-up as 330.77 bp (95% CI: 241.55, 420.00). This
equates to age-related attrition of 38.33 bp yr21 (95% CI: 27.99, 48.67), a value not significantly
different from estimates of annual attrition obtained from longitudinal studies of LTL in cohorts not
included in the current dataset (e.g. 40.2 bp yr21 [42] and 31.0 bp yr21 [43]). Thus, our data are of
sufficient quality to show a robust effect of age on LTL of the expected magnitude over follow-up
periods of as little as 5.9 years.3.3. Do smokers have shorter leukocyte telomere length than non-smokers?
At baseline, smokers had shorter LTL than non-smokers in 17 cohorts and the difference was significant
in four of these (figure 2a). At follow-up, smokers had shorter LTL in 15 cohorts and the difference was
significant in four; non-smokers had significantly shorter LTL in one cohort (figure 2b). Meta-analyses
showed that the association between smoking and LTL was significant overall at baseline and follow-
up, with shorter LTL in smokers at both time-points (table 2, models 2 and 3 respectively). The
causation and mixed hypotheses both predict that the difference in LTL between smokers and non-
smokers should increase over time (figure 1). Three cohorts followed this pattern with a significantly
stronger association between smoking and LTL at follow-up and one cohort showed the opposite
pattern with a significantly stronger association at baseline, but for 14 of the cohorts, there was no
difference in the association between smoking and LTL between baseline and follow-up (figure 3a).
Meta-analysis of the difference in the association between smoking and LTL between time-points
showed that this was not significantly different from zero overall (table 2, model 4). Thus, the pattern
of cross-sectional findings within cohorts does not support the causation or mixed hypotheses (figure 1).
Since there was no evidence for a difference in association between time-points, we combined the
data across time-points to obtain a single, more powerful, estimate of the cross-sectional association
between smoking and LTL for each cohort. Combining across time-points yielded five cohorts with
significantly shorter LTL in smokers, and meta-analysis confirmed significantly shorter LTL in
smokers overall (table 2, model 5). In the current analysis, the observed association between smoking
and LTL (from model 5) equates to smokers having telomeres 84.61 bp (95% CI: 22.62, 146.61) shorter
than non-smokers.
(a) (b)
Figure 3. The difference in LTL between smokers and non-smokers does not increase with more years of smoking. (a) Forest plot showing
the lack of difference in association between smoking and LTL between baseline and follow-up (model 4). For key see figure 2. (b) Scatterplot
showing that the association between smoking and LTL does not change as the mean age of the cohort increases. Each point represents one
cohort and the area of the point is proportional to the weight in model 5. The solid black line shows the non-significant estimate from a
random-effects meta-regression model obtained by adding mean age of the cohort as a moderator to model 5. The ribbon shows 95% CI for
the estimate. The dashed line indicates no effect of smoking on LTL.
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10There was significant heterogeneity among cohorts in the size of the association between smoking
and LTL (table 2, model 5). Given that most smokers start smoking in their teenage years, the causal
and mixed hypotheses both predict that the difference in LTL between smokers and non-smokers
should increase as the mean age of the cohort increases. Our dataset allows a powerful test of this
prediction, because mean age at baseline varies from 26 (in DMHDS) to over 80 years (in LBC1921; a
far greater age range than the effect of follow-up interval analysed in model 4). Therefore, we added
mean age at the midpoint between baseline and follow-up as a moderator to model 5. The slope of
the resulting meta-regression was not significantly different from zero (parameter estimate and 95%
CI: ,0.00 [20.01, 0.01], p ¼ 0.9450; figure 3b). Thus, there is no evidence that the difference in LTL
between smokers and non-smokers becomes larger in older participants who are likely to have
smoked for longer. In conclusion, neither the within-cohort nor the among-cohort effects of age show
the patterns in LTL predicted by the causation and mixed hypotheses (figure 1).3.4. Do smokers have faster telomere attrition than non-smokers?
We used the longitudinal LTL attrition rates of participants to ask whether LTL attrition was faster in
smokers than in non-smokers. Two cohorts (JLRCS and MONICA) had significantly faster LTL attrition
in smokers, while one cohort (CCS) had significantly faster LTL attrition in non-smokers (figure 4a).
Meta-analysis showed no significant association between smoking and the rate of LTL attrition overall,
and no significant heterogeneity in the size of the association between cohorts (table 2, model 6). The
parameter estimate from model 6 equates to a difference in LTL attrition rate between smokers and non-
smokers of 20.51 bp yr21 (95% CI: 22.09, 1.08). This difference in rate of attrition due to smoking is a
negligible proportion (1.32%) of the 38.32 bp loss per year that we estimated for ageing.
To establish the robustness of the lack of an association between smoking and LTL attrition, we
conducted three further analyses of the rate of LTL attrition. First, to test whether any single cohort
was having a substantial influence on the association between smoking and LTL attrition, we explored
the effect of excluding each cohort from model 6 in turn. In all cases, the resulting parameter estimate
for the association between smoking and LTL attrition was not significantly different from zero
(electronic supplementary material, table S2). The inclusion of just one cohort (MONICA) is
responsible for the parameter estimate being negative; when this cohort is excluded, the parameter
estimate for the association between smoking and telomere attrition was effectively zero (parameter
estimate and 95% CI: 0.00 [20.05, 0.05], p ¼ 0.9947).
Second, to test whether the lack of an association between smoking and LTL attrition is explained by
the inclusion of cohorts with high LTL measurement error in the dataset, we re-ran model 6 weighting
(a) (b)
Figure 4. The rate of LTL attrition is virtually identical in smokers and non-smokers and this absence of a difference in attrition does
not change over 54 years of smoking. (a) Forest plot showing the lack of an association between smoking and LTL attrition rate
measured longitudinally within participants (model 6). For key see figure 2. (b) Scatterplot showing the lack of association between
the effect of smoking on LTL attrition and mean age at baseline. The solid black line shows the non-significant estimate from a
random-effects meta-regression model obtained by adding mean age at baseline as a moderator to model 6. The dashed line
indicates no association between smoking and LTL attrition. For key see figure 3b.
royalsocietypublishing.org/journal/rsos
R.Soc.open
sci.6:190420
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The resulting parameter estimate for the association between smoking and telomere attrition was now
slightly positive, but still not significantly different from zero (parameter estimate and 95% CI: 0.08
[20.20, 0.36], p ¼ 0.5694).
Third, we explored whether there was any evidence for bias in our selection of cohorts. We started
with a systematic literature search, but due to the lack of suitable data in published articles, the final
dataset assembled is an opportunity sample. For half of the cohorts included we had some idea of the
effects of smoking expected due to information available in published articles [17], but for the
remaining half we were blind to the expected findings at the time of requesting the data (table 1). Re-
running model 6 on just the latter nine cohorts produced no change in the conclusion that smoking
does not affect LTL attrition rate (parameter estimate and 95% CI: 20.04 [20.17, 0.09], p ¼ 0.5797).
3.5. Can the small difference in attrition explain the cross-sectional difference in leukocyte
telomere length?
Although the difference in attrition between smokers and non-smokers was negligible and not
significantly different from zero, attrition was still slightly faster in smokers (i.e. a negative parameter
estimate) when we included all cohorts in the meta-analysis and weighted them in the conventional
fashion (inverse-variance). Using the estimates of the difference in LTL from model 5 and the
difference in attrition from model 6, we asked how many years of smoking would be necessary to
generate the cross-sectional difference in LTL between smokers and non-smokers. The parameter
estimates from models 5 and 6 in table 2 suggest that LTL is 84.61 bp shorter in smokers compared to
non-smokers and that LTL attrition rate 0.51 bp yr21 faster in smokers than non-smokers. Thus,
assuming a linear effect of smoking on attrition, 167.43 years of smoking would be required to
generate the observed cross-sectional difference in LTL between smokers and non-smokers. Note that
when we weighted cohorts by their measurement error in model 6 (see above), LTL attrition was
estimated as 2.29 bp yr21 faster in non-smokers than smokers. Under this scenario, no number of
years of smoking can generate the observed baseline difference in LTL.
3.6. Is the effect of smoking on the rate of leukocyte telomere length attrition nonlinear?
Thus far, our tests of the causation hypothesis have assumed a sustained effect of smoking on the rate of
LTL attrition that continues unabated in smokers (as illustrated in figure 1). To test whether an effect of
royalsocietypub
12smoking on the rate of LTL attrition is present in newer smokers and diminishes or reverses over time
with continued smoking, we added age at baseline as a moderator to model 6. The slope of the
resulting meta-regression was not significantly different from zero (parameter estimate and 95% CI:
,0.00 [20.00, 0.01], p ¼ 0.3019; figure 4b). Thus, there is no evidence for an association between
smoking and LTL attrition in younger people (who have more recently started smoking) that
subsequently diminishes over time.lishing.org/journal/rsos
R.Soc.open
sci.6:1904204. Discussion
Using meta-analytic methods to compare LTL dynamics over a mean of 8.6 years of follow-up in 4678
current smokers and 7901 non-smokers, we found no evidence for significantly faster telomere
attrition in smokers. Our analyses confirmed that LTL shortened with increasing age and that smokers
had shorter LTL than non-smokers at all measured time-points. However, there was no evidence that
this cross-sectional difference increased with age, as would be expected if smoking causes LTL
attrition. There was also no significant difference in the rate of LTL attrition measured within smokers
and non-smokers. Moreover, the negligibly greater rate of attrition observed in smokers was totally
insufficient to produce the cross-sectional difference between smokers and non-smokers within a
human lifetime. Taken together, these findings provide no support for the hypothesis that smoking
causes a sustained increase in the rate of LTL attrition.
The above conclusion is based on assuming a linear effect of smoking on telomere attrition over time
(figure 1). There are strong mechanistic reasons for assuming a linear model. Current smoking causes a
chronic elevation in the levels of oxidative stress and inflammation, both of which are implicated in
accelerated telomere attrition in a dose-dependent manner. However, some authors have attempted to
explain the lack of an effect of smoking on telomere attrition in previous studies by assuming that
smoking has an initial accelerating effect on attrition that rapidly reverses with continued smoking
[20–22]. The evidence claimed for this nonlinear effect is the strong positive correlation observed in
all longitudinal studies between baseline telomere length and telomere attrition: individuals starting
with longer telomeres have faster attrition than those starting with shorter telomeres. On the basis of
this observation, Farzaneh-Far et al. [22] have argued that any rapid initial shortening of telomeres
caused by smoking is subsequently offset by a length-related decrease in attrition caused by this
‘homeostatic’ process. However, it has now been recognized that a more parsimonious explanation for
the observed correlation between baseline LTL and attrition rate is regression to the mean resulting
from measurement error [29]. Thus, the apparent ‘homeostatic’ mechanism proposed to account for
nonlinear attrition rates in smokers is largely a statistical artefact. Importantly, our analysis of the
current dataset provided no evidence that the association between smoking and LTL attrition changed
over time, as would be expected if an accelerating effect of smoking was present early on and
subsequently diminished or reversed. It is a limitation of our dataset that our youngest cohorts were
already in their 20s, meaning that the majority of smokers are likely to have been smoking for at least
a decade. It is therefore possible that we could have missed an effect of smoking on LTL attrition that
occurred prior to the baseline telomere measurements. To decisively rule out a highly nonlinear effect
of smoking that is completely restricted to the decade immediately after starting smoking, we need to
know whether telomere length differences in childhood precede the initiation of smoking [17].
Cohorts are currently becoming available in which it will be possible to test this prediction.
Is the lack of an effect of smoking on telomere attrition a limitation of low power? Some authors have
argued that longitudinal studies have low power for detecting effects of smoking on attrition due to their
small sample sizes [20,21,26]. While it is often the case that sample sizes are larger in cross-sectional than
longitudinal studies, this is not true of the 18 cohorts included in the current analysis, where the same
individuals were studied both cross-sectionally and longitudinally. Furthermore, longitudinal studies
eliminate the substantial between-individual variation in LTL by measuring within-individual changes
in LTL and are therefore much more powerful than cross-sectional studies of the same sample size for
detecting effects of smoking on telomere dynamics [44]. Importantly, our meta-analysis of 18
longitudinal datasets shows no significant heterogeneity among cohorts in the effect of smoking on
telomere attrition rates. This suggests first, that it is valid to compute a summary estimate for the
difference in attrition between smokers and non-smokers, and second, that the precision of the meta-
analysis exceeds that of its constituent cohorts [39]. The resulting negligible difference in attrition
between smokers and non-smokers of 20.51 bp yr21 is therefore the most powerful estimate yet of the
association between smoking and telomere attrition.
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correlation between baseline and follow-up LTL measurements suggests substantial variation in
measurement error among cohorts [27]. While this error should not cause bias in our estimates of the
association between smoking and LTL attrition, it will affect the precision of these estimates [30]. We
found no evidence that weighting cohorts according to the correlation between baseline and follow-up
measurements caused a significant change in our estimate of the association between smoking and
LTL attrition. Indeed, the weighted meta-analysis actually yielded a marginally lower rate of LTL
attrition in smokers compared to non-smokers. This result strengthens the evidence against the
causation hypothesis, because it implies that no amount of smoking could yield the observed cross-
sectional difference in LTL.
Is it possible that some kind of bias is masking a true effect of smoking on telomere attrition?
Restricting our dataset to participants that survived to follow-up undoubtedly introduces selection
based on mortality (e.g. [26]). Since both smoking and short LTL have been argued to cause earlier
mortality, mortality is a collider variable in our analyses. Selection based on the value of a collider is
usually discussed in the context of producing spurious associations between independent variables,
so-called ‘collider bias’ (e.g. [45]), but collider bias can also potentially mask true associations. For
example, by selecting against individuals who die between baseline and follow-up, longitudinal
studies could underestimate the effects of smoking on telomere attrition, because they retain only
smokers who are resistant to the damaging effects of tobacco smoke. However, this argument fails to
explain the substantial difference in baseline LTL between smokers and non-smokers that we
observed, even in the studies where the age of participants at baseline was quite advanced. If
selection bias is present, it should affect cross-sectional associations as well as measures of attrition,
yet we found no change in the difference in LTL between smokers and non-smokers with increasing
cohort age (figure 3b). Furthermore, selection based on mortality should be negligible in cohorts in
their 20s or 30s, but substantial for cohorts over 60, yet we found no effect of baseline age on the size
of the association between smoking and LTL attrition, despite an age range of over 54 years. Taken
together, the above findings argue against selection bias masking a true association between smoking
and LTL attrition.
We deliberately elected to use raw attrition measures in our analyses as opposed to effect sizes
derived from multiple regression models controlling for known sources of variation in telomere
attrition rates (such as baseline telomere length). Our rationale for this choice came from recent work
showing that controlling for baseline telomere length in multiple regression models of telomere
attrition biases the effects of any predictor variables that also correlate with telomere length at
baseline (typically age, sex and smoking status; [30]). This latter finding suggests that the published
effects of variables such as age, sex and smoking status on telomere attrition are likely to exaggerate
the true effect sizes of these variables, raising the probability of type I errors above 5% (see also [46]).
This could explain why some of our individual cohorts report significant effects of smoking on LTL
attrition [18,19].
A corollary of our decision to use raw LTL and attrition measures in our analyses is that we did not
control for potential confounds including age and sex. However, the majority of the nine published
studies that we have been able to find reporting effects of smoking on telomere attrition use multiple
regression models that control for age and sex [18–26]. Considered together, the results of these nine
studies support the general conclusions of the current paper: there is strong evidence for an effect of
smoking on LTL (six out of eight studies that tested for a difference report that LTL is significantly
shorter in smokers), but there is much less evidence for an effect of smoking on LTL attrition (only
two out of nine studies report that LTL attrition is significantly faster in smokers) (see [17, table 3]).
Furthermore, it is reassuring that our meta-analysis of the cross-sectional effect of smoking on LTL
produces a summary effect size for smoking (20.13) that is similar to that reported in another meta-
analysis based on published effect sizes derived from cross-sectional studies that control for potential
confounds such as age and sex (20.11 in [1]). Thus, the conclusions drawn from analyses that do and
do not control for age and sex appear very similar and there is no evidence to suggest that controlling
for age and sex would alter the conclusions of the current paper.
In the absence of any evidence supporting the hypothesis that smoking causes a sustained increase in
the rate of LTL attrition, it is worth considering the alternative hypothesis that selective adoption is
occurring. Selective adoption predicts that a difference in LTL between future smokers and non-
smokers should exist prior to the start of smoking. Two alternative causal pathways could underlie
selective adoption [17]. First, it is possible that telomere shortening could directly cause changes in
behaviour. There is emerging evidence that telomere shortening causes changes in regulation of more
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14than 140 genes [47,48], making this idea theoretically possible (although none of the genes identified thus
far as regulated by telomere shortening is obviously linked to behaviour, let alone smoking). A second
causal pathway yielding selective adoption is that exposure to a third variable both shortens LTL and
makes subsequent adoption of smoking more likely. One possibility, that still attributes a causal role
to smoke exposure, is that parental smoking both causes early-life LTL attrition and increases a child’s
probability of starting smoking. A recent study found that telomere loss between birth and young
adulthood was positively associated with distance to a major road at the residential address occupied
at birth [49], suggesting air pollution as a possible cause of childhood telomere attrition. Thus, it is
possible that passive smoking in early life could cause telomere attrition. However, it is not necessary
to attribute any causal role to smoke exposure to explain the data in the current paper. We suggest
that a plausible third variable supported by substantial existing data is exposure to early-life
adversity. Developmental telomere attrition is accelerated by exposure to early-life adversity of
various types including family disruption and physical and emotional abuse [50–53]. Furthermore,
these same sources of early-life adversity are also associated with a greater probability of starting
smoking, smoking more and being less likely to quit [54–56]. Thus, although childhood LTL has not
thus far been examined as a predictor of adult smoking behaviour, there is strong indirect evidence to
expect associations to exist. It is worth noting that the available data lead us to predict not only an
association between childhood LTL and the presence of adult smoking, but also between childhood
LTL and the amount smoked. An association between LTL and amount smoked is often regarded as
strong evidence for the causation hypothesis [1]. However, it is now clear that such evidence is
equally compatible with selective adoption.
In conclusion, we find no evidence that smoking accelerates the rate of leucocyte telomere attrition in
adults. Our findings should prompt more critical appraisal of data underlying the claim that smoking is
the most important, ‘broad range’ ageing accelerator [5,6]. Where these data come from cross-sectional
studies, and in vivo experimental studies are lacking, we suggest that selective adoption should be
considered as an alternative explanation for associations between smoking and biomarkers of ageing
such as telomere length.
Our findings have consequences for how measures of telomere length are used in human
epidemiology and behavioural ecology. Under the currently prevailing view that certain types of
behaviour cause accelerated telomere attrition, measures of telomere length can be used to identify
those behaviours that are most harmful and those that are protective [57]. Changes in telomere
dynamics could also potentially be used to monitor the somatic consequences of behaviour change
(e.g. the positive effects of quitting smoking). However, if we are correct, and selective adoption turns
out to be an explanation for observed associations with telomere length, then we need to reinterpret
shorter telomeres as a relatively static biomarker as opposed to as a dynamic consequence of current
adult behaviour.
As a final note, although we found no evidence that smoking accelerates the rate of leucocyte
telomere attrition, our results do not preclude the many other well-established negative effects of
smoking on human health and longevity. We chose to focus on smoking in the current paper simply
because there are more data available on the associations between smoking and telomere length than
for any other behaviour [17]. Our intention was to question prevalent assumptions in the telomere
dynamics literature concerning the mechanisms underlying associations between behaviour and
telomere length, rather than to question the damaging effects of smoking.
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